News - Vaccines

Filter

Current filters:

Vaccines

Popular Filters

101 to 125 of 260 results

GSK to boost vaccines business with 250 million-euro buy of Swiss firm Okairos

30-05-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday (May 29) revealed that it has acquired Swiss closely-held…

BiotechnologyGlaxoSmithKlineMergers & AcquisitionsOkairosPharmaceuticalVaccines

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst

20-05-2013

While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative…

Anti-viralsBiotechnologyFinancialHVTN 505PharmaceuticalResearchVaccines

Infectious disease treatments market driven by growth in middle-income to low-income countries

17-05-2013

The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

Merger between Intercell and Vivalis planned to complete soon

14-05-2013

French biotech firm Vivalis (Euronext: VLS) previously-announced acquisition of Intercell (ICEL.VI) in…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

India-developed rotavirus vaccine demonstrates strong efficacy

14-05-2013

In a public-private partnership, the Indian government's Department of Biotechnology (DBT) and Bharat…

Asia-PacificBharat BiotechPharmaceuticalResearchROTAVACVaccines

Takeda to acquire Inviragen, gaining rights to promising vaccines

09-05-2013

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) has entered into a definitive agreement to…

DENVaxInviragenMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsVaccines

Leading Russian vaccines producer Petrovax acquired by Pharmstandard

07-05-2013

Russian drugmaker Pharmstandard is to acquire Petrovax Pharm, one of the country's largest producers…

Abbott LaboratoriesMergers & AcquisitionsPetrovax FarmPharmaceuticalPharmstandardVaccines

Sanofi says pediatric vaccine Hexyon/Hexacima approved in Europe

22-04-2013

The European Commission has approved French drug major Sanofi (Euronext: SAN) subsidiary Sanofi Pasteur's…

EuropeHexacimaHexyonMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Abbott Labs told it cannot acquire Russia's Petrovax Farm

22-04-2013

The Russian government has imposed a ban on the sale of Petrovax Farm, one of Russia's leading vaccines…

Abbott LaboratoriesBiotechnologyMergers & AcquisitionsPetrovax FarmVaccines

Adult vaccines market controlled by GSK and Merck

15-04-2013

The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

More collaboration needed to raise vaccination rates in developing nations, says analyst

12-04-2013

More collaboration is needed between pharmaceuticals companies, public health organizations and governments…

GlobalHealthcarePharmaceuticalResearchVaccines

Sanofi Pasteur MSD files for EU approval of "Quadrivalent" flu vaccine

11-04-2013

Sanofi Pasteur MSD, the joint venture between French drug major Sanofi (Euronext: SAN) vaccines unit…

EuropeMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

GlaxoSmithKline cleared for $91M flu vaccine plant in USA; Gets CRL on Q-Plan H5N1

27-03-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and The Texas A&M University System (TAMUS) say that the US…

GlaxoSmithKlineNorth AmericaPharmaceuticalProductionQ-Plan H5N1RegulationVaccines

GlaxoSmithKline and Abbott to start production in Ukraine

19-03-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

Sinovac rockets on strong data for Enterovirus 71 vaccine

15-03-2013

Chinese vaccines maker Sinovac Biotech Ltd. (Nasdaq: SVA) saw its shares leap 53% to $4.88 in morning…

Asia-PacificEnterovirus 71PharmaceuticalRegulationResearchSinovacVaccines

Astellas ends FLT3 deal with Ambit; reports on flu vaccine ASP7374

12-03-2013

The US subsidiary of Japanese drug major Astellas Pharma (TYO: 4503) and USA-based privately held firm…

Ambit BiosciencesASP7374Astellas PharmaLicensingOncologyPharmaceuticalquizartinibResearchVaccines

Russian government to develop domestic production of vaccines

01-03-2013

The Russian government is considering investing in the domestic production of vaccines, by building a…

EuropeFinancialGenericsPharmaceuticalProductionVaccines

FDA delays approval of Dynavax' Heplisav, issuing CRL

26-02-2013

Dynavax Technologies ( Nasdaq: DVAX) saw its shares plunge as much as 38% to $1.84 in pre-market trading…

Anti-viralsBiotechnologyDynavax TechnologiesHeplisavNorth AmericaRegulationVaccines

CHMP recommends approval of Sanofi Pasteur's Hexyon/Hexacima 6-1 pediatric vaccine

22-02-2013

CHMP recommends approval of Sanofi Pasteur's Hexyon/Hexacima 6-1 pediatric vaccine

EuropeHexacimaHexyonPharmaceuticalRegulationSanofiSanofi PasteurVaccines

Sanofi eyes big plans for China

11-02-2013

French pharmaceutical giant Sanofi (Euronext: SAN) plans to complete building a large plant for the production…

Asia-PacificPharmaceuticalProductionSanofiSanofi PasteurVaccines

Generex highlights pipeline potential of Antigen Express subsidiary

10-02-2013

Canada-based Generex Biotechnology (OTC Bulletin Board: GNBT) last week provided an overview of the current…

AE37Anti-viralsAntigen ExpressBiotechnologyGenerex BiotechnologyOncologyPharmaceuticalResearchVaccines

GAVI Alliance funds vaccines for cervical cancer in developing countries

08-02-2013

More than 180,000 girls in eight developing countries are set to receive protection against the leading…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalRest of the WorldVaccinesWomen's Health

101 to 125 of 260 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top